bright light therapy < bromocriptine < bruxism

Facettes :

List of bibliographic references indexed by bromocriptine

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
001E61 (2010)	Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
002384 (2009)	Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; M. Chiharu Yamaguchi [Japon] ; Yusuke Awa [Japon] ; Masashi Yano [Japon] ; Mitsuru Yanagisawa [Japon] ; Makoto Kobayashi [Japon] ; Yoshinori Higuchi [Japon] ; Tomohiko Ichikawa [Japon] ; Tomonori Yamanishi [Japon] ; Takamichi Hattori [Japon] ; Satoshi Kuwabara [Japon]	Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease
002418 (2009)	Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Yiong-Huak Chan [Singapour] ; Nigel C. K. Tan [Singapour]	Bromocriptine use and the risk of valvular heart disease
003125 (2006)	Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Seung Woo Park [Corée du Sud] ; Won Yong Lee [Corée du Sud]	Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
003150 (2006)	Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]	The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
003714 (2005)	Mariese A. Hely [Australie] ; John G. L. Morris [Australie] ; Wayne G. J. Reid [Australie] ; Robert Trafficante [Australie]	Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
003F71 (2003)	Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon] ; Kazuko Hasegawa [Japon] ; Hideki Origasa [Japon] ; Hisayuki Kowa [Japon]	Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
004316 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
004759 (2001)	Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]	Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    bromocriptine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024